Mechanisms of resistance to imatinib (STI571) and prospects for combination with conventional chemotherapeutic agents
Author:
Publisher
Elsevier BV
Subject
Pharmacology (medical),Infectious Diseases,Cancer Research,Pharmacology,Oncology
Reference36 articles.
1. Lessons learned from the development of an Abl tyrosine kinase inhibitor for chronic myelogenous leukemia;Druker;J Clin Invest,2000
2. Tyrosine kinase activity and transformation potency of bcr-abl oncogene products;Lugo;Science,1990
3. Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome;Daley;Science,1990
4. Induction of a chronic myelogenous leukemia-like syndrome in mice with v-abl and BCR/ABL;Kelliher;Proc Natl Acad Sci USA,1990
5. Selective inhibition of the platelet-derived growth factor signal transduction pathway by a protein-tyrosine kinase inhibitor of the 2-phenylaminopyrimidine class;Buchdunger;Proc Natl Acad Sci USA,1995
Cited by 39 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Role of Sphingolipids in Hematological Malignancies: Myeloproliferative Disorders;Bioactive Sphingolipids in Cancer Biology and Therapy;2015
2. A conversation with Jeffrey Settleman;Science-Business eXchange;2014-10
3. Wogonin induces cell cycle arrest and erythroid differentiation in imatinib-resistant K562 cells and primary CML cells;Oncotarget;2014-08-10
4. Alantolactone induces apoptosis in chronic myelogenous leukemia sensitive or resistant to imatinib through NF-κB inhibition and Bcr/Abl protein deletion;Apoptosis;2013-04-24
5. Pharmacogenetics and Pharmacogenomics;Emery and Rimoin's Principles and Practice of Medical Genetics;2013
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3